⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Andrew MammenM.D.

Psychiatry & Neurology · Baltimore, MD 21224

NPI: 1619923786

Share:𝕏fin

36

🟠 Elevated

Risk Flags

High opioid rate vs specialty peersExtreme cost outlier (population + peer)Extreme brand-name preferenceHigh long-acting opioid rate vs peers

Risk indicators are statistical patterns, not allegations. Learn more

229

Total Claims

$1.6M

Drug Cost

17

Beneficiaries

$93K

Cost/Patient

Risk Score Breakdown 36/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid rate vs specialty peers+10
Cost per patient outlier+10
Brand-name preference+8
Long-acting opioid rate+8

Score components are additive. Read full methodology

Peer Comparison vs. 10,307 Psychiatry & Neurology providers

+6953%

Cost per patient vs peers

$93K vs $1,323 avg

+1127%

Brand preference vs peers

62.0% vs 5.0% avg

⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.

Opioid Prescribing

5.2%

Opioid Rate

12

Opioid Claims

$536

Opioid Cost

100.0%

Long-Acting Rate

Brand vs Generic

38% generic

Brand: 142 claims · $1.6M

Generic: 87 claims · $5,647

Patient Profile

68

Avg Age

Female

1.60

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About